Xponance Inc. Decreases Stock Holdings in Revvity, Inc. (NYSE:RVTY)

Xponance Inc. cut its holdings in Revvity, Inc. (NYSE:RVTY) by 2.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,124 shares of the company’s stock after selling 398 shares during the quarter. Xponance Inc.’s holdings in Revvity were worth $1,796,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of the business. Czech National Bank lifted its stake in shares of Revvity by 0.5% in the 1st quarter. Czech National Bank now owns 21,713 shares of the company’s stock valued at $2,280,000 after purchasing an additional 99 shares during the period. Garrison Asset Management LLC lifted its position in Revvity by 0.5% during the second quarter. Garrison Asset Management LLC now owns 21,328 shares of the company’s stock valued at $2,236,000 after buying an additional 103 shares during the period. TriaGen Wealth Management LLC boosted its holdings in shares of Revvity by 2.3% during the 2nd quarter. TriaGen Wealth Management LLC now owns 4,767 shares of the company’s stock valued at $500,000 after buying an additional 107 shares in the last quarter. Guinness Asset Management LTD grew its position in shares of Revvity by 3.3% in the 2nd quarter. Guinness Asset Management LTD now owns 3,587 shares of the company’s stock worth $376,000 after buying an additional 116 shares during the period. Finally, Inspire Investing LLC increased its stake in shares of Revvity by 2.9% in the 1st quarter. Inspire Investing LLC now owns 4,190 shares of the company’s stock worth $440,000 after acquiring an additional 117 shares in the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Leerink Partnrs raised shares of Revvity to a “strong-buy” rating in a research note on Monday, July 8th. Jefferies Financial Group upped their price target on Revvity from $115.00 to $125.00 and gave the stock a “hold” rating in a research note on Monday, July 29th. Leerink Partners initiated coverage on Revvity in a research note on Monday, July 8th. They set an “outperform” rating and a $125.00 price objective for the company. Citigroup boosted their target price on Revvity from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, July 30th. Finally, TD Cowen raised their price target on Revvity from $130.00 to $141.00 and gave the company a “buy” rating in a report on Tuesday, July 30th. Eight research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $126.00.

Insider Buying and Selling

In other Revvity news, insider Joel S. Goldberg sold 3,500 shares of the business’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $117.86, for a total transaction of $412,510.00. Following the completion of the sale, the insider now owns 33,400 shares of the company’s stock, valued at $3,936,524. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.60% of the stock is owned by insiders.

Revvity Trading Up 3.5 %

Shares of NYSE:RVTY opened at $126.34 on Friday. The stock’s 50-day simple moving average is $119.75 and its two-hundred day simple moving average is $110.91. The stock has a market capitalization of $15.59 billion, a price-to-earnings ratio of 104.41, a PEG ratio of 2.90 and a beta of 1.05. Revvity, Inc. has a 52-week low of $79.50 and a 52-week high of $128.15. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.98 and a current ratio of 2.27.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Monday, July 29th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.12 by $0.10. Revvity had a net margin of 6.26% and a return on equity of 7.34%. The company had revenue of $691.70 million for the quarter, compared to the consensus estimate of $690.33 million. During the same quarter last year, the firm posted $1.21 earnings per share. The firm’s revenue was down 2.5% compared to the same quarter last year. Analysts expect that Revvity, Inc. will post 4.75 EPS for the current year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 8th. Stockholders of record on Friday, October 18th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.28 annualized dividend and a dividend yield of 0.22%. Revvity’s dividend payout ratio (DPR) is 23.14%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.